Peptide fundamentals

Lyophilization: How Freeze-Drying Preserves Peptides

Lyophilization, or freeze-drying, turns a peptide solution into a dry, porous solid by freezing it and then removing the ice under vacuum. This explainer walks through the three stages of the process, the temperature limits that govern it, and the chemistry that makes a dry solid more stable than a solution. It closes with what cake appearance and residual moisture results on a certificate of analysis actually describe.

What lyophilization is#

Lyophilization (freeze-drying) is a drying process that removes water from a material without passing it through the liquid phase. A solution is first frozen, and the ice is then converted directly to vapor under reduced pressure, a phase change called sublimation. The FDA's inspection guide for the process describes it as three interdependent stages: freezing, primary drying (sublimation) and secondary drying (desorption).[1] Each stage depends on the one before it, so a change in how a sample is frozen can change how it dries.

The product of a successful cycle is a porous solid usually called a cake. The cake keeps roughly the shape and volume of the frozen fill, because the solids that were dissolved in the water stay behind as a rigid network once the ice has gone.

Stage 1: Freezing#

As a solution cools, pure water crystallizes as ice and the dissolved material is pushed into the shrinking spaces between the crystals. This remaining liquid becomes steadily more concentrated and is known as the freeze-concentrate. What happens to it next depends on the solutes. Some components crystallize at a characteristic eutectic temperature. Others never crystallize and instead become an amorphous glass: a rigid, disordered solid. The temperature at which the maximally freeze-concentrated solution turns to a glass is written Tg′ ("T-g-prime").

The FDA guide notes that the product is typically frozen to a temperature well below its eutectic point before drying begins.[1] Freezing also sets the structure of the eventual cake. A published review of freeze-drying process design reports that controlled ice nucleation tends to produce larger ice crystals, which leave larger pores after sublimation and therefore lower resistance to vapor flow during drying.[2] The same review describes annealing, a hold at a temperature above the final freezing temperature, as a way to grow ice crystals and reduce that resistance.[2]

Stage 2: Primary drying and the collapse temperature#

In primary drying, the chamber pressure is lowered and gentle heat is supplied so that ice sublimes. A drying front moves down through the frozen material, leaving a dry porous layer above it. Primary drying is usually the longest part of the cycle, and the review cited above describes it as the stage where ice sublimation takes place and as more predictable than freezing.[2]

The governing limit in this stage is temperature. If the solid next to the drying front warms too much, the amorphous matrix softens enough to flow and the pore structure falls in on itself. The temperature at which this happens is the collapse temperature (Tc); for amorphous materials it is related to, but not identical with, Tg′. Process designers keep the product several degrees below Tc; the review reports a typical temperature margin of about 2 to 5 °C depending on cycle length.[2] The FDA guide expresses the same principle in terms of the eutectic point, describing a product temperature held at least 4 to 5 degrees below it during primary drying.[1]

Stage 3: Secondary drying#

When the ice is gone, the cake still contains water that never froze: molecules bound within the amorphous matrix or adsorbed on its surfaces. Secondary drying removes this water by desorption while the chamber stays under vacuum.[1][2] For typical amorphous formulations, the design review reports that residual water below 0.5% by weight is commonly achieved.[2]

Drier is not automatically better. The same review points out that a particular product may be more stable at an intermediate residual water content than at the lowest one achievable, which is why moisture targets are set from stability data rather than by default.[2] The FDA guide makes a similar point from the inspection side: moisture limits should be established on worst-case data.[1]

Why a dry solid is more chemically stable#

Peptides and proteins degrade in solution through a small number of well-characterized chemical and physical pathways. Water takes part in several of them directly, either as a reactant or as the medium that lets reacting groups meet. A review of protein instability summarizes the main routes, and notes that in the dried form the hydrolysis and other in-solution pathways are largely removed.[3] The table below gives a chemistry-level overview.

Common degradation pathways for peptides and proteins, summarized from a 2022 review.[3] Analytical methods for detecting the resulting impurities are covered in the HPLC and mass spectrometry explainer.
PathwayWhat changes chemicallyWhy water matters
HydrolysisA covalent bond, typically a peptide bond in the backbone, is cleaved by water; the rate rises under both acidic and alkaline conditions.[3]Water is the reactant, so removing it removes the main route.
DeamidationThe side-chain amide of asparagine (and more slowly glutamine) is converted to a carboxylic acid, often via a cyclic succinimide intermediate, giving aspartate and isoaspartate products; Asn-Gly and Asn-Ser sequences are especially prone.[3]The reaction proceeds fastest in neutral to alkaline solution and depends on buffer and ionic strength.[3]
OxidationMethionine is the most susceptible residue; tryptophan, histidine, cysteine and tyrosine can also be oxidized.[3]Dissolved oxygen, light and trace transition metals act as triggers.[3]
AggregationMolecules associate into dimers and larger species, often after hydrophobic regions become exposed.[3]Agitation, air-water interfaces and heat promote it in solution.[3]

These products matter analytically because they show up as impurities. A deamidated or oxidized form differs in mass and often in chromatographic retention from the parent sequence, which is how they appear in a purity assessment or in the methods described in HPLC and mass spectrometry explained.

Excipients and bulking agents#

Many freeze-dried materials contain added ingredients, called excipients, chosen for how they behave during drying. Two broad roles are common. A crystalline bulking agent with a high eutectic temperature, such as mannitol or glycine, forms a scaffold that supports the cake and allows primary drying above Tg′ without visible collapse.[2] An amorphous stabilizer (often called a lyoprotectant), such as sucrose, stays glassy and surrounds the peptide in the dried matrix.[2]

The two roles have opposite requirements. Crystallization is desirable for a bulking agent but can be detrimental for an amorphous stabilizer, because a stabilizer that crystallizes no longer forms the glass it was added to provide.[2] Not every lyophilized peptide contains excipients; a research material may be freeze-dried from a simple solution. Where excipients are present, a certificate of analysis or product documentation should state them, because they contribute to the weight of the solid.

Reading cake appearance and residual moisture on a COA#

A certificate of analysis for a lyophilized material often reports an appearance result and a water content result. Both are process indicators. For a general walkthrough of the document, see how to read a certificate of analysis.

Appearance#

Appearance is usually reported as a short description, for example "white to off-white lyophilized cake or powder." The FDA guide lists cake volume and cake appearance among the critical aspects of the finished material, and describes meltback as a form of collapse caused by incomplete sublimation, in which part of the product passed through a liquid state.[1] It notes that meltback can leave moisture pockets and a different physical form that may be less stable.[1] Conversely, the design review cautions that a cake that is not cosmetically elegant is not necessarily out of specification.[2] A shrunken or cracked cake is therefore a reason to look at the moisture and purity data rather than a conclusion on its own.

Residual moisture and Karl Fischer titration#

Water content in lyophilized solids is most often measured by Karl Fischer (KF) titration. USP general chapter <921> Water Determination describes the titrimetric method as based on the quantitative reaction of water with an anhydrous solution of sulfur dioxide and iodine, and lists direct, residual and coulometric variants alongside azeotropic and gravimetric methods.[4] The coulometric variant is described as a micro-method suited to small amounts of water, which makes it practical for small lyophilized samples.[4]

A COA line such as "Water (KF): 3.1% w/w" (an illustrative value) means that water made up that fraction of the sample's mass at the time of testing. It is not a purity result, but it affects how other results are interpreted, because water adds to the weighed mass without being peptide. ICH Q5C, the international guideline on stability testing of biotechnological products, lists moisture level of lyophilized products among the characteristics monitored in stability programs.[5] When comparing batches, it helps to check that the same method and units were used.

Renuvia Labs publishes each batch's COA in the COA library when testing is complete.

Evidence and limitations

This article describes general freeze-drying principles drawn from regulatory guidance and reviews written mainly about protein products; individual peptides can behave differently depending on sequence and formulation. Specific temperatures and moisture figures cited here come from those sources or are labeled as illustrative, and are not specifications for any particular material. Cycle design and acceptance limits are set case by case from development and stability data.

Questions researchers ask

What is lyophilization of peptides?
Lyophilization is freeze-drying: a peptide solution is frozen, and the ice is then removed under vacuum by sublimation, followed by a warmer step that removes bound water. The result is a dry, porous solid called a cake. Removing water slows the solution-phase chemistry that degrades peptides.
What is the difference between primary and secondary drying?
Primary drying removes ice by sublimation at low temperature and pressure, and is usually the longest stage. Secondary drying removes water that never froze, bound within or on the dried solid, by desorption. Together they set the final residual moisture.
What is the collapse temperature in freeze-drying?
The collapse temperature is the point at which the amorphous solid next to the drying front softens enough to flow, so the pore structure falls in. For amorphous materials it is related to Tg′, the glass transition temperature of the freeze-concentrated solution. Cycles are designed to keep the product a few degrees below it during primary drying.
Why is a lyophilized peptide more stable than a solution?
Several degradation pathways, such as hydrolysis and deamidation, need water as a reactant or as the medium in which reacting groups meet. In the dried solid, those in-solution routes are largely removed. Dried materials are still monitored over time, and stability programs track moisture alongside other characteristics.
What does Karl Fischer water content mean on a COA?
It is the percentage of the sample's mass that is water, measured by a titration in which water reacts with iodine and sulfur dioxide. It is not a purity value, but it matters because water contributes to the weighed mass. USP <921> describes the method and its variants.

References

  1. U.S. Food and Drug Administration. Lyophilization of Parenteral (7/93). Guide to Inspections of Lyophilization of Parenterals, Inspection Guides. Source
  2. Tchessalov S, Shalaev E, Bhatnagar B, et al. Practical Advice on Scientific Design of Freeze-Drying Process: 2023 Update. Pharmaceutical Research. 2023. doi:10.1007/s11095-023-03607-9 Source
  3. Akbarian M, Chen SH. Instability Challenges and Stabilization Strategies of Pharmaceutical Proteins. Pharmaceutics. 2022;14(11):2533. doi:10.3390/pharmaceutics14112533 Source
  4. United States Pharmacopeia. General Chapter <921> Water Determination.
  5. ICH Q5C. Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological Products (EMA scientific guideline PDF). Source

Educational content for laboratory researchers. It describes research and analytical methods and is not medical advice. Renuvia Labs products are for laboratory research use only and are not for human or animal consumption.